


Autoimmune
2025-06-16

To advance Systemic lupus erythematosus (SLE) research, GemPharmatech has developed a humanized SLE mouse model by transferring PBMCs from SLE patients into immunodeficient mice (NCG mice). This model replicates key disease features, including high levels of human auto-antibodies and renal immune complex deposition. Furthermore, this model responds to B-cell targeted therapeutic antibodies, demonstrating its utility in evaluating novel therapeutic modalities.
More infomation about blogs

Let us know which event you're attending and we'd be happy to connect with you.
This website will store cookies on your computer. These cookies are used to collect information about how you interact with this website and enable us to remember you. We use this information to improve and customize your browsing experience, as well as to analyze and collect relevant data and metrics about visitors on this website and other platforms. For more information about the cookies we use, please refer to our privacy policy
If you decline, your information will not be tracked when visiting this website. A cookie will be used in your browser to remember your preference settings that you have not accepted.
